News
News: AstraZeneca and Qure.ai complete 5M AI-powered chest scans, enhancing early lung cancer detection across 20+ countries ...
A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...
The screenings identified nearly 50,000 individuals with lung nodules considered high risk for cancer, leading to their ...
3d
The Scarborough News on MSNFrom running marathons to struggling to walk a mile a dayIt’s mid-morning and Sean Kelly, 58, from Scarborough has just got back from his daily walk. This time last year, Sean was ...
There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...
The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...
A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...
Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
Veteran actor Sharmila Tagore was diagnosed with zero-stage lung cancer in 2023. Here's what the early-stage diagnosis means, how it was treated, and why early detection matters.
11d
Health and Me on MSNYoung Non-Smoker Dies Of Terminal Lung Cancer After Being Misdiagnosed With Anxiety; Early Signs To Watch ForA healthy 36-year-old non-smoker from the UK, was misdiagnosed with anxiety for months before discovering he had terminal ...
Study could have particular relevance for the UK where the 5-year survival rate for lung cancer is 16 per cent and has improved only slightly during the past 40 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results